Search results for ceftriaxone - 8 results

news

How did gonorrhoea become a drug-resistant superbug?

10 April 2018 | By European Pharmaceutical Review

Scientists show how the gonorrhoea bacterium resists last-resort antibiotic ceftriaxone while maintaining a robust growth rate...

article

Developments in stability testing and evaluation

4 September 2019 | By David Elder (JPAG Chair), Dr Conor Jamieson (Sandwell and West Birmingham NHS Trust), Dr Gary Scrivens (Pfizer), Dr Jonathan Bright (AstraZeneca), Dr Maria Krisch (FreeThink Technologies), Dr Paul Fullerton (AMRI), John Cleverley (Clarivate Analytics), Rachel Orr (GlaxoSmithKline), Susan Smith (AstraZeneca)

The Joint Pharmaceutical Analysis Group (JPAG) held a stability meeting at the Royal Society of Chemistry’s headquarters in London earlier this year. Attended by 65 delegates, its focus was on developments in stability testing and evaluation. Here follows a summary of the presentations made at the meeting.

news

Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment

18 April 2024 | By Catherine Eckford (European Pharmaceutical Review)

Based on its novel mechanism of action, GSK’s gepotidacin could provide a new oral option for the treatment of gonorrhoea.

news

FDA accepts Teflaro sNDA for filing

16 February 2016 | By Victoria White

If approved, this filing will expand the label of Teflaro beyond adults to include the treatment of children two months of age and older...

news

Zoliflodacin shows promise in treating uncomplicated gonorrhea

8 November 2018 | By Iqra Farooq (European Pharmaceutical Review)

Zoliflodacin was found to be effective in curing all rectal gonorrheal infections in patients during a Phase II clinical trial...

news

Novartis launches not-for-profit COVID-19 medications portfolio

17 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

The portfolio will be offered to low- and lower-middle-income countries to help financially strained healthcare systems care for COVID-19 patients.

news

New strategy could improve generic drug quality assessments

10 January 2022 | By Hannah Balfour (European Pharmaceutical Review)

Population pharmaceutical quality assessment could be used to improve the quality consistency of generic drugs, suggests study.

news

Antibiotics ‘no longer effective’ for childhood infections, finds study

2 November 2023 | By Caroline Peachey (European Pharmaceutical Review)

Australian-led study highlights ‘alarmingly high’ rates of resistance to commonly-prescribed antibiotics in the Asia-Pacific region.